Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.61509 | 25 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.60543 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.60729 | 26 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.53396 | 25 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.56397 | 27 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.64947 | 25 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.61076 | 25 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.58749 | 26 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.55943 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.60099 | 27 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.58659 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.58699 | 27 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.5945 | 26 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.59488 | 26 |